1. Clinical experiences with ruxolitinib in symptomatic patients with myeloproliferative neoplasm with chronic kidney disease. Issue 1 (January 2014) Authors: Tabarroki, Ali; Visconte, Valeria; Rogers, Heesun J.; Sekeres, Mikkael A.; Samaras, Christy; Lichtin, Alan; Duong, Hien K.; Englehaupt, Ricki; Cinalli, Tracy; Dodd, Kristin; Desamito, John; Rouphail, Basel; Altman, Jessica K.; Stein, Brady L.; Tiu, Ramon V. Journal: Leukemia & lymphoma Issue: Volume 55:Issue 1(2014:Jan.) Page Start: 213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Is rituximab sub‐optimally dosed in indolent B cell lymphoma?. (2nd May 2016) Authors: Sawalha, Yazeed; Rouphail, Basel; Jia, Xuefei; Dean, Robert M.; Hill, Brian T.; Jagadeesh, Deepa; Pohlman, Brad L.; Smith, Mitchell R. Journal: British journal of haematology Issue: Volume 174:Number 5(2016) Page Start: 721 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗